文献速递泌尿生殖妇产影像US

卵巢-附件报告和数据系统(O-RADS)超声评分对手术切除率的影响

The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate.
PubMed 文献 · Radiology · 2024-01-01

这项多中心回顾性研究纳入2011年1月至2014年12月间因卵巢或附件病变伴非急性症状、在O-RADS US发布前接受超声后手术切除的377例患者,盲法回顾记录影像特征并计算O-RADS US 2022版风险评分。42%(157/377)的手术切除病变回顾性符合O-RADS US 2类,其中恶性不足1%(1/157);以O-RADS US 4为恶性预测最佳阈值,敏感度94%(68/72)、特异度64%(195/305)、阳性预测值38%(68/178)、阴性预测值98%(195/199)。作者结论认为这些患者本可接受影像随访或保守管理。

要点

  • 42%(157/377)的手术切除病变回顾性符合O-RADS US 2类,其中恶性不足1%(1/157)。
  • O-RADS US 2类病变中54%(86/157)为非肿瘤性、45%(70/157)为皮样囊肿或其他良性肿瘤。
  • 以O-RADS US 4为恶性预测最佳阈值,敏感度94%、特异度64%、阴性预测值98%。

核心结论

  • 在O-RADS US风险评分发布前因卵巢及附件病变接受手术的非急性症状患者中,近半数(42%)手术切除病变回顾性符合O-RADS US 2022版2类标准,这些患者本可接受影像随访或保守管理。

研究设计与样本

  • 多中心回顾性研究,纳入2011年1月至2014年12月间因卵巢囊性病变伴非急性症状、在O-RADS US引入前接受超声后行手术切除的患者377例;研究者对最终诊断盲法记录病变影像特征和O-RADS US风险评分;采用Mann-Whitney检验和Fisher精确检验,P < .05为差异有统计学意义。

关键影像表现/征象

  • 手术切除病变中42%(157/377)回顾性评为O-RADS US 2类。
  • O-RADS US 2类病变中54%(86/157)为非肿瘤性,45%(70/157)为皮样囊肿或其他良性肿瘤,不足1%(1/157)为恶性。

诊断标准与关键数值

  • 以O-RADS US 4为恶性预测最佳阈值:敏感度94%(68/72),特异度64%(195/305),阳性预测值38%(68/178),阴性预测值98%(195/199)。

临床应用与阅片要点

  • 对非急性症状的卵巢囊性病变,按O-RADS US 2022版评分记录形态学特征,2类病变可考虑影像随访或保守管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The Ovarian-Adnexal Imaging Reporting and Data System (O-RADS) US risk score can be used to accurately stratify ovarian lesions based on morphologic characteristics. However, there are no large multicenter studies assessing the potential impact of using O-RADS US version 2022 risk score in patients referred for surgery for an ovarian or adnexal lesion. Purpose To retrospectively determine the proportion of patients with ovarian or adnexal lesions without acute symptoms who may have been managed conservatively by using the O-RADS US version 2022 risk score. Materials and Methods This multicenter retrospective study included patients with ovarian cystic lesions and nonacute symptoms who underwent surgical resection after US before the introduction of O-RADS US between January 2011 and December 2014. Investigators blinded to the final diagnoses recorded lesion imaging features and O-RADS US risk scores. The frequency of malignancy and the diagnostic performance of the risk score were calculated. The Mann-Whitney test and Fisher exact test were performed, with P < .05 indicating a statistically significant difference. Results A total of 377 patients with surgically resected lesions were included. Among the resected lesions, 42% (157 of 377) were assigned an O-RADS US risk score of 2. Of the O-RADS US 2 lesions, 54% (86 of 157) were nonneoplastic, 45% (70 of 157) were dermoids or other benign tumors, and less than 1% (one of 157) were malignant. Using O-RADS US 4 as the optimal threshold for malignancy prediction yielded a 94% (68 of 72) sensitivity, 64% (195 of 305) specificity, 38% (68 of 178) positive predictive value, and 98% (195 of 199) negative predictive value. Conclusion In patients without acute symptoms who underwent surgery for ovarian and adnexal lesions before the O-RADS US risk score was published, nearly half (42%) of surgically resected lesions retrospectively met the O-RADS US 2 version 2022 criteria. In these patients, imaging follow-up or conservative management could have been offered. © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Fournier in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Shen L, Sadowski EA, Gupta A, et al. The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection Rate. Radiology. 2024. PMID: 39377674. doi:10.1148/radiol.240044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。